Single Center Experience with Periprocedural Safety in Stenting Cervical and Intracranial Atherosclerotic Disease

Introduction: We reviewed our institutional experience to compare our single institution, single surgeon results to larger published series. Methods: This is a retrospective review of 51 consecutive patients treated from March 2010 through November 2013 by a single surgeon at LSUHSCShreveport. The procedures included were all stents placed for the treatment of both cervical carotid and intracranial atherosclerotic occlusive disease. All cervical carotid procedures were performed with cerebral protection when anatomically possible. Intracranial stenosis was treated with angioplasty and stent and no distal protection. Results: Of our 51 patients 33 were male (64.7%), 18 were female (35.3%). The mean age was 58.2. The 51 patients represented 52 procedures with 52 different lesions treated with angioplasty and stenting. All patients included had symptomatic disease. Primary endpoint for poor outcome was symptomatic stroke, death, or myocardial infarction within 30 days. There was no incidence of symptomatic stroke, death, or myocardial infarction. Non-stroke morbidity was 5.4%. These included groin hematoma and acute stent thrombosis. Conclusions: The periprocedural results of our institution with regard to cervical carotid and intracranial angioplasty and stenting of atherosclerotic disease indicate comparable safety in these procedures to internationally published figures.